FDA issues draft guidance on reporting manufacturing changes for gene therapies
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy